Clinical Trial Update: HighFLO Study - HighLife Trans-septal Mitral Valve Replacement (TSMVR) Feasibility Study of the Open Cell CLARITY Valve [NA]

View source ↗

Summary

The HighFLO study is a feasibility trial of trans-septal mitral valve replacement using the Open Cell CLARITY valve by HighLife SAS, currently recruiting for mi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Snippet

Sponsor: HighLife SAS | Conditions: Mitral Regurgitation | NA | Status: RECRUITING